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Abstract
Introduction
A simple cost-effective strategy to pre-screen for targeted HIV testing can have substantial
benefit in high burden and resource limited settings. A 4-item (previous hospitalisation,
orphanhood, poor health status, and recurring skin problems) screening tool to identify ado-
lescents living with HIV has previously shown high sensitivity in healthcare facility settings.
We validated this screening tool in a community setting, in Harare, Zimbabwe in a commu-
nity-based HIV prevalence survey.
Methods
A community-based HIV prevalence survey was conducted among individuals aged 8–17
years with guardian consent and child assent and residing in 7 communities during the
period February 2015 to December 2015. Participants without previously diagnosed HIV
were evaluated for the probability of having HIV using the screening tool. HIV status was
defined using an anonymous HIV test which was done using Oral Mucosal Transudate
(OMT). A questionnaire was also administered to ascertain self-reported HIV status and
screening tool items. The validity of a 4-item screening tool was tested. Sensitivity and
specificity of the screening tool was assessed against the HIV status based on OMT
result.
Results
Prevalence survey participants were 5386 children who had an HIV test result, aged 8–17
years. However, 5384, who did not report testing HIV positive and responded to all screen-
ing tool item questions were included in the validation. Their median age was 12 (IQR: 10–
15) years, 2515 (46.7%) were male. HIV prevalence was 1.3% (95% CI:1.0–1.8%). The 4-
item screening tool had poor accuracy with an area under the receiver operating curve of
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0.65(95% CI: 0.60–0.72) at a cut-off score1. Its sensitivity was 56.3% (95% CI:44.0–
68.1%) and specificity of 75.1% (95% CI:73.9–76.3%), PPV of 2.9% (95% CI:2.1–3.9%)
and a NPV of 99.2% (95% CI:98.9–99.5%). The number needed to test to diagnose one
child using the screening tool was 55% lower than universal testing for HIV.
Conclusion
Use of the 4-item screening tool could be a strategy that can be adopted to identify children
living with HIV in a community setting in resource limited settings by reducing the number
needed to test compared to universal testing since it is inexpensive, easy to administer and
not harmful. However, screening items adapted to a community setting need to be explored
to improve the performance of the screening tool.
Introduction
The coverage of antiretroviral therapy (ART) is lower in children compared to adults (45% vs
54% in 2016) globally, the key reason being high rates of undiagnosed HIV infection in this
age group.[1] The World Health Organization (WHO) recommends provider-initiated HIV
testing and counselling (PITC) for all individuals attending health-care facilities in high HIV
prevalence settings (adult HIV prevalence1%).[2] However, several studies have demon-
strated that HIV testing rates among adolescents attending health facilities remain low due to
implementation challenges which include unavailability of manpower and testing kits.[3, 4]
Community-based strategies are being more widely employed to increase coverage of HIV
testing, but the yield is lower than that for facility-based HIV testing.[5] However, commu-
nity-based universal testing may not be cost-effective in resource-limited settings, particularly
among children who have lower HIV prevalence than adults.[6] Using a pre-testing screening
tool to identify children at risk of being HIV-positive may increase yield of HIV testing, and be
a more efficient and cost-effective approach in resource-limited settings.
We previously developed an HIV screening tool for children and adolescents (aged 6–16
years) at risk of being HIV-positive, who could then be targeted for HIV testing and counsel-
ling. The tool, consisting of 4 items (previous hospitalisation, orphanhood, poor health status,
and recurring skin problems), with a cut-off score of1 and designed for use in primary care
settings by low-cadre, non-professional health workers, had 80% sensitivity and 66% specificity
when validated in seven primary health care settings in Harare, Zimbabwe.[7]
In this study, embedded in a community-based HIV prevalence survey, we validated the
performance the 4-item screening tool to identify children and adolescents at risk of being
HIV-positive in a community setting in Harare, Zimbabwe.
Materials and methods
Study population and sampling
During the period February 2015 to December 2015, a cross-sectional HIV prevalence survey
was conducted among children aged 8–17 years from all households located in 130 randomly
selected Census Enumeration Areas (Zimbabwe Census 2012) in seven urban high density
suburbs in south western Harare, Zimbabwe.[8]
Community-based HIV screening in adolescents
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Ethical approval and consent
The study was approved by the Medical Research Council of Zimbabwe and Ethical Review
Committees of the London School of Hygiene and Tropical Medicine and the Biomedical
Research and Training Institute. Written consent was obtained from all guardians of the par-
ticipants and participants aged 13 to 17 years and assent from children aged 8 to12 years to
respond to all the screening questions and to an anonymous HIV test and referral for a diag-
nostic HIV.
Data collection
Participants were asked to respond to an interviewer-administered questionnaire that collected
socio-demographic data including the screening tool item questions;
• orphanhood status (Is your mother alive?, Is your father alive?: Yes/No)
• previous hospitalisation (Have you ever been admitted to hospital?: Yes/No)
• recurring skin problems (Have you been having recurring skin problems?: Yes/No)
• poor health (How do you rate your general health?: Excellent, Good, Fair Poor)
Data were collected by trained research assistants on electronic tablets (Nexus 7 2013) using
Open Data Kit (ODK) and data transferred to an MS Access database.
Confidential HIV testing was performed by the same research assistants who were trained
to collect oral mucosal transudate (OMT) and test using Oraquick HIV-1/2 test kits. The HIV
results were recorded on paper forms and the data entered into an MS Access database using
Cardiff TELEFORM Intelligent Character Optical Mark Recognition Software (Version 10.9).
Statistical analysis
All analyses were performed using STATA version 13 (StatCorp, Texas, USA).
The performance of the screening tool was validated after excluding and also after including
those who self-reported previously having tested HIV-positive in this analysis. The responses
to the screening tool items were coded or recoded as binary (Yes = 1, No = 0, fair/poor
health = 1and excellent/good health = 0). The total score was calculated as the sum of the
numerical values of the responses to the screening items with a possible minimum score of 0
and maximum score of 4. HIV status was defined based on OMT result and self-reported HIV
with documented clinical evidence.
HIV prevalence and the 95% confidence interval estimate was calculated allowing for clus-
tering by community (surburb). The associations between HIV (using the OMT test result)
and age, sex, orphanhood status, previous hospitalisation, recurring skin problems and poor
health were examined using student t-tests and Chi-squared tests for binomial proportions.
Chi-square test for trend was used to check the trend in the prevalence of HIV status by score.
Logistic regression with random effects was used to estimate the odds ratios (OR) and 95%
CI associated with HIV status, for each item. Items significantly associated with being HIV-
positive (p<0.1) were included in the final multivariable logistic model to be considered in the
screening tool for a community setting. Multicollinearity between the screening items in the
final model were checked using the logistic regression post estimations programs for data
analysis.
Optimum cut-off for the screening tool was checked using a receiver operating characteris-
tic curve (ROC). The area under the curve (AUC) and sensitivity, specificity, positive predic-
tive (PPV) and negative predictive values (NPV) for the screening tool were determined using
Community-based HIV screening in adolescents
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the OMT HIV test result which was assumed to be the gold standard without error for the pur-
poses of this analysis and also including self-reported HIV status.
The number needed to test to identify one child living with HIV after the application of the
screening tool (NNT+) items and score levels was calculated. The reduction in NNT+ com-
pared to universal testing to identify one child living with HIV were determined for different
screening items and score levels.
Results
A total of 5486 children aged 8–17 years from 3397 randomly selected households participated
in the prevalence survey, with 38 excluded because no information was available on orphan-
hood status (Fig 1). A total of 64 who self-reported that they were living with HIV were initially
excluded from the analysis and of the remaining 5384 participants, 2515 (46.7%) were male,
with a median age of 12 years (IQR 10–15) (Table 1). The cluster weighted prevalence of HIV
was estimated at 1.3% (95% CI: 1.0–1.8%).
Using a cut-off of p<0.1, all the screening items and age were significantly associated with
testing HIV positive and were included in the multivariable logistic model. However, health
status rating and presence of skin problems and age were not associated with testing HIV posi-
tive in the multivariable model.
At a cut-off score of1 (confirmed by ROC analysis), the 4-item tool yielded a sensitivity
of 56.3% (95% CI:44.0–68.1%) and specificity of 75.1% (95% CI:73.9–76.3%), PPV 2.9% (95%
CI: 2.1–3.9%), NPV 99.2% (95% CI: 98.9–99.5%) and area under the curve (AUC) 0.65(95% CI
0.60–0.72).
Fig 1. Selection of the validation study sample.
https://doi.org/10.1371/journal.pone.0204891.g001
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There was no participant who tested HIV positive who scored 4. The prevalence of HIV
increased with screening score, from 0.7%, 3.0%, 1.8% and 9.1% among those scoring 0, 1, 2
and 3 respectively (p<0.001 using chi-square test for trend). A score1 was more likely
among children aged 13–17 years compared to those aged 8–12 years (31.9% vs 19.2%,
p<0.001) but there was no significant difference by gender (25.4% vs 25.2%, p = 0.817).
The number needed to test to diagnose one child living with HIV using the screening tool
was 34 as compared to 76 using universal testing for HIV, which was a reduction of 55%
(Table 2). One child would be falsely classified as “not at risk” for every 176 children screened
using the tool. Demographic characteristics of those falsely classified showed that 61.3% were
female and 54.8% were aged between 13–17 years.
To test the performance of the tool using HIV status which includes participants who self-
reported and showed documented clinical evidence of living with HIV, the weighted preva-
lence of HIV was estimated at 2.4% (95% CI: 2.0–2.9%). The screening tool had a sensitivity of
71.4% (95% CI:63.2–78.7%) and specificity of 75.1% (95% CI:73.9–76.3%), PPV 7.0% (95% CI:
5.8–8.5%), NPV 99.0% (95% CI: 98.6–99.3%) and area under the curve (AUC) 0.73 (95% CI
0.70–0.77) (Table 3).
Discussion
Provider-initiated HIV testing and counselling (PITC) has been recommended by the WHO
since 2007 for everyone attending health facilities in high HIV prevalence settings.[9] Facility-
based testing relies on an individual attending a health care facility with an illness, and HIV
diagnosis therefore often occurs after development of advanced disease.[10, 11] Therefore,
community-based strategies are being increasingly considered to address the substantial levels
of undiagnosed HIV in high HIV prevalence settings. Community-based HIV testing strate-
gies have shown high acceptability and uptake among adults and likely identify individuals at
an earlier stage of the disease sprectrum.[12, 13] However, the yield is lower, which may make
community-based approaches less affordable in resource-limited settings. Therefore, strategies
that target those at risk of being HIV-infected for HIV testing and counselling are increasingly
Table 1. Baseline characteristics stratified by HIV status.
Characteristic All HIV Status Univariate OR
(95% CI)
p-value Multivariable OR
(95% CI)
p-value
Positive Negative
N = 5384 n = 71 (%col) n = 5313(%col)
Age (years)
8–12 years 2784(51.2%) 27(38.0%) 2757 (51.9%) 1 1
13–17 years 2600(48.3%) 44 (61.9%) 2556 (48.1%) 1.7(1.2–2.5) 0.002 1.4(0.9–2.2) 0.065
Median age (IQR) 12(10–15) 14(11–16) 12 (10–15)
Sex
Female 2869(53.3%) 40(56.3%) 2829 (53.2%) 1
Male 2515(46.7%) 31(43.7%) 2484 (46.7%) 0.9(0.7–1.1) 0.206 Excluded
Screening Items
Been admitted to hospital before (Yes) 306(5.7%) 11(15.5%) 295 (5.5%) 3.1 (1.9–5.2) <0.001 2.8(1.6–5.1) 0.001
Had recurring skin problems (Yes) 205(3.8%) 5 (7.0%) 200 (3.8%) 1.9 (1.0–3.8) 0.050 1.4(0.7–2.8) 0.362
One or both parents deceased(Yes) 882(16.4%) 26 (36.6%) 856 (16.1%) 3.0 (2.4–3.8) <0.001 2.7 (1.9–3.6) <0.001
Have poor health (Yes) 194(3.6%) 5 (7.0%) 189 (3.5%) 2.0 (1.2–3.5) 0.010 1.4(0.8–2.4) 0.362
P-value: For OR (Odds Ratio)
https://doi.org/10.1371/journal.pone.0204891.t001
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being considered, particularly in children in whom HIV prevalence is much lower than that in
adults.
We previously developed and evaluated a screening tool to identify older children and ado-
lescents attending primary care facilities at risk of vertically transmitted HIV, who would then
be targeted for HIV testing.[14] The 4-item screening tool demonstrated a high sensitivity of
80% and halved numbers need to test to identify one HIV-positive child.[7] The validation in
the community involved the use of the tool in an asymptomatic population in which the preva-
lence of HIV was<3% and the disease spectrum of HIV was earlier and included less severe
cases. This resulted in the sensitivity to be lower (56% versus 80%) and specificity higher (75%
vs 66%) than when the same tool was validated in a hospital setting where children suspected
of having advanced HIV were more likely to be found.[7] The main difference was the lower
prevalence of the health-related screening items, that is, skin problems and poor health, which
are likely to be more prevalent among children attending health facilities with advanced dis-
ease. In both settings, orphanhood and previous hospitalisation remained significantly associ-
ated with HIV.
Use of the screening tool needs to be weighed against the resources required for universal
HIV screening when HIV prevalence is low and the potential benefits. In a community setting
with an HIV prevalence of 1.3% to 2.4%, the 4-item tool reduced the number that would need
to be tested to identify one HIV-positive child from 76 using universal HIV testing to 34. This
is comparable to a reduction from 22 to 10 if the 4-item screening tool was implemented at a
healthcare facility level.[7] The prevalence of HIV in this sub-population was <3%, and the
high NPV provides assurance that in children who score 0, the probability that they are not liv-
ing with HIV is 99.2%. However, it is also important to note that the PPV and NPV are depen-
dent upon the prevalence of HIV in the population screened. Although the tool ability to
Table 2. Properties of 4-item community screening tool excluding participants with previously diagnosed HIV (HIV Prevalence = 1.3%).
Sn (%)
(95%
CI)
Sp (%)
(95% CI)
PPV (%)
(95% CI)
NPV(%)
(95% CI)
AUC NNT
+ tool
(95% CI)
Reduction in NNT+ compared to universal
testing (%)
Screening Item
Been admitted to hospital
before
15.5
(8.0–
26.0)
94.4(93.8–
95.1)
3.6(1.8–6.3) 98.8(98.5–
99.1)
0.55(0.50–
0.59)
28(16–55) 63
Had recurring skin problems 7.0(2.3–
15.7)
96.2(95.7–
96.7)
2.4(0.8–5.6) 98.7(98.4–
99.0)
0.51(0.48–
0.55)
41(18–
126)
46
One or both parents
deceased
36.6
(25.5–
48.9)
83.9(82.9–
84.9)
2.9(1.9–4.3) 99.0(98.7–
99.3)
0.60(0.55–
0.66)
34(23–52) 55
Have poor health 7.0(2.3–
15.7)
96.4(95.9–
96.9)
2.6(0.84–
5.9)
98.7(98.4–
99.0)
0.52(0.49–
0.55)
39(17–
119)
49
Screening Tool Score Cut-
off
1 56.3
(44.0–
68.1)
75.1(73.9–
76.3)
2.9(2.1–3.9) 99.2(98.9–
99.5)
0.65(0.60–
0.72)
34(25–48) 55
2 7.0(2.3–
15.7)
96.4(95.9–
96.9)
2.6(0.8–5.9) 98.7(98.4–
99.0)
0.52(0.49–
0.55)
39(17–
120)
48
3 2.8(0.3–
9.8)
99.6(99.4–
99.8)
8.0(1.0–
26.0)
98.7
(98.4.99.0)
0.51(0.49–
0.53)
13(4–102) 84
Sn -Sensitivity, Sp-Specificity, PPV—Positive Predictive Value, NPV—Negative Predictive Value, NNT+ tool—Number Needed to Test to identify 1 HIV-infected after
application of screening tool, AUC:Area Under Curve
https://doi.org/10.1371/journal.pone.0204891.t002
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discriminate those at risk or not at risk of HIV was poor (AUC = 65%), the consequences of a
false negative or false positive are reasonable. In our population, if the screening tool were
applied, 32% of children misclassified as being at risk would have benefited from knowing
their HIV status. as It is important to point out that even in the absence of all screening items,
HIV testing should be offered to all children if resources are available. However, the tool mis-
classified 44% of children who were positive as not being at risk, which means this can give a
false sense of assurance to nearly half the children living with undiagnosed HIV in need of an
HIV test. Therefore, the results of the screening tool should not be considered as definitive and
there is need to develop a tool adapted to a community setting.
The findings from this validation study only show that when resources are limited and uni-
versal testing is not feasible, this simple, inexpensive and not harmful tool can be adopted for
targeted testing to reduce the number needed to test for HIV.
The strengths of the study are a large sample size and high participation rates. The random
selection of participants increases the reliability of the study. The results can be generalised to
other African settings with similar HIV prevalence. However, there are several limitations to
this study. It is possible that some participants may have underreported their HIV status and
hence might not have been undiagnosed. OMT tests results were used as a gold standard, but
it is an imperfect gold standard as it can give a false negative result in people taking ART,
potentially leading to misclassification, and affecting the tool’s sensitivity.[15]
Inclusion of previously diagnosed children would have resulted in spectrum bias and given
inflated and potentially misleading estimates of the performance of tool as shown by the
Table 3. Properties of 4-item community screening tool including participants with previously diagnosed HIV (HIV Prevalence = 2.4%).
Sn (%)
(95%
CI)
Sp (%)
(95% CI)
PPV (%)
(95% CI)
NPV (%)
(95% CI)
AUC NNT
+ tool
(95% CI)
Reduction in NNT+ compared to universal
testing (%)
Screening Item
Been admitted to hospital
before
26.4
(19.3–
34.5)
94.5(93.8–
95.1)
11.2(8.0–
15.1)
98.0(97.6–
98.4)
0.60(0.57–
0.64)
9(7–13) 77
Had recurring skin
problems
16.4
(10.7–
23.6)
96.2(95.7–
96.7)
10.3(6.7–
15.1)
97.8(97.3–
98.1)
0.56(0.53–
0.59)
10(7–15) 75
One or both parents
deceased
45.7
(37.3–
54.3)
83.9(82.9–
84.9)
6.9(5.4–8.8) 98.3(97.9–
98.7)
0.65(0.61–
0.69)
14(11–19) 63
Have poor health 20.0
(13.7–
27.6)
96.4(95.9–
96.9)
12.9(8.8–
18.1)
97.9(97.4–
98.2)
0.58(0.55–
0.62)
8(6–11) 80
Screening Tool Score Cut-
off
1 71.4
(63.2–
78.7)
75.1(73.9–
76.3)
7.0(5.8–8.5) 99.0(98.6–
99.3)
0.73(0.69–
0.77)
14(12–17) 63
2 25.7
(18.7–
33.8)
96.4(95.9–
96.9)
15.9(11.4–
21.3)
98.0(97.6–
98.4)
0.61(0.57–
0.65)
6(5–9) 84
3 11.4
(6.7–
17.9)
99.6(99.4–
99.7)
41.0(25.6–
57.9)
97.7(95.9–
98.1)
0.56(0.53–
0.58)
2(2–4) 94
Sn -Sensitivity, Sp-Specificity, PPV—Positive Predictive Value, NPV—Negative Predictive Value, NNT+ tool—Number Needed to Test to identify 1 HIV-infected after
application of screening tool AUC-Area Under the Curve
https://doi.org/10.1371/journal.pone.0204891.t003
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increase of the sensitivity of the screening tool from 56% to 71% when previously diagnosed
children were included. In addition, the association of a particular screening item with HIV
may change over time thereby affecting the performance of the tool, for example, orphanhood
levels may drop as ART is scaled up. Further, extrapolation bias might have occurred because
the screening tool was developed for 6-16year age group, targeting vertically infected children
but was validated in the 8-17year group which might have included horizontally infected chil-
dren. The screening items used might not have been valid in this population and new screen-
ing items might need to be explored, like schooling and sexual health [15]. This might explain
the fact that those with a score of 1 were older, 13-17years (32% vs 19%, p<0.001) and there
was no significant difference by gender.
Conclusion
HIV testing and counselling is the critical entry point to accessing HIV treatment. The 2015
WHO guidelines recommend treatment of all individuals living with HIV regardless of age
and disease stage.[16] Practical and cost-effective strategies are therefore urgently needed if we
are to meet the UNAIDS target to test 90% of all individuals living with HIV by 2020.[17]
While universal testing is the gold standard, the use of a screening tool may be a more efficient
and potentially a cost-effective strategy particularly among adolescents, an age-group that has
a high burden of undiagnosed HIV but a relatively low HIV prevalence and requires checking
on only 4- simple items which can be asked by lower level healthcare workers.[6, 8, 18] How-
ever, a screening tool will need to be tailored to the community and local context and impor-
tantly any testing strategy needs to combine with strategies to facilitate linkage with HIV care
for those who test HIV-positive.
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